Royal Jelly Supplementation Ameliorated Immune Impairment via Inhibition of Oxidative Stress in Low Micronutrient-induced Immunodeficient Mice

Han-Ol Kwon¹, Minhee Lee¹, Yun-Hi Cho¹, Woojin Jun² and Jeongmin Lee^{1, 3,}

¹Department of Medical Nutrition, Kyung Hee University, Yongin, South Korea

²Department of Food and Nutrition, Cheonnam National University, Gwangju, South Korea

³Research Institute of Clinical Nutrition, Kyung Hee University, Seoul, South Korea

Cite this paper:
Han-Ol Kwon, Minhee Lee, Yun-Hi Cho, Woojin Jun and Jeongmin Lee. Royal Jelly Supplementation Ameliorated Immune Impairment via Inhibition of Oxidative Stress in Low Micronutrient-induced Immunodeficient Mice. Journal of Food and Nutrition Research. 2017; 5(2):74-79. doi: 10.12691/jfnr-5-2-1

Abstract

The effect of royal jelly (RJ) on the survival and immune dysfunctions of C57BL/6 mice induced by low micronutrient supplementation was investigated. Female C57BL/6 mice were supplemented with 0.2% or 1% royal jelly following induction of immune deficiency by 7.5% low micronutrient intake. The administration was maintained for 16 weeks for mortality assay and 10 weeks for the immunological analysis. Supplementation of 1% RJ was found to extend the median survival time in immune deficient mice. Although dysfunction of T- and B-cell mitogenesis was observed in primary cultured splenocytes during micronutrient deficiency, 1% RJ supplementation significantly increased T- and B-cell response against mitogens. In addition, 1% RJ supplementation partially recovered the abnormal alteration in cytokine secretion, indicated by the decreased secretion of T-helper 1 cytokines and increased secretion of T-helper 2 cytokines resulting from low micronutrient levels. The hepatic vitamin E level was significantly decreased (p<0.05) following micronutrient deficiency, in accordance with the increased hepatic lipid peroxidation level. However, 1% RJ supplementation reduced hepatic lipid peroxidation, which may result from the restoration of the hepatic vitamin E level. Therefore, the present study indicated that 1% RJ supplementation may ameliorate the premature mortality in mice through the restoration of immune dysfunctions, which may result from antioxidative ability of RJ in immune deficient mice caused by low micronutrient intake.

Keywords:
malnutrition royal jelly antioxidant immunodeficiency cytokine

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Brown, K.H., Hess, S.Y., Vosti, S.A. and Baker, S.K. “Comparison of the estimated cost-effectiveness of preventive and therapeutic zinc supplementation strategies for reducing child morbidity and mortality in sub-Saharan Africa,” Food Nutr Bull, 34. 199-214. 2013.
[2]	Nunnari, G., Coco, C., Pinzone, M.R., Pavone, P., Berretta, M., Di, Rosa. M., Schnell, M., Calabrese, G. and Cacopardo, B, “The role of micronutrients in the diet of HIV-1-infected individuals,” Front Biosci, 4. 2442-2456. 2012.
[3]	Campa, A., Shor-Posner, G., Indacochea, F., Zhang, G., Lai, H., Asthana, D., Scott, G.B. and Baum, M.K., “Mortality risk in selenium-deficient HIV-positive children,” J Acquir Immune Defic Syndr Hum Retrovirol, 20. 508-513. 1999.
[4]	Oka, H., Emori, Y., Kobayashi, N., Hayashi, Y. and Nomoto, K., “Suppression of allergic reactions by royal jelly in association with the restoration of macrophage function and the improvement of Th1/Th2 cell responses,” Int Immunopharm, 1. 521-532. 2001.
[5]	Hanes, J. and Simuth, J., “Identification and partial characterization of the major royal jelly protein of the honey bee (Apis melifera L.),” J Apic Res, 31.22-26. 1992.
[6]	Howe, S.R., Dimick, P.S. and Benton, A.W., “Composition of freshly harvested and commercial royal jelly,” J Apic Res, 24.2-61. 1985.
[7]	Palma, M.S., “Composiotion of freshly harvested Brazilian royal jelly; identification of carbohydrates from the sugar fraction,” J Apic Res, 31.42-44. 1992.
[8]	Chouaib, S., Welte, K., Mertelsmann, R. and Dupont, T., “PGE2 acts at two distinct pathways of T lymphocyte activation: inhibition of IL-2 production and down regulation of transferrin expression,” J Immunol, 135. 1172-1179. 1985.
[9]	Zibadi, S., Rohdewald, P.J., Park, D. and Watson, R.R., “Reduction of cardiovascular risk factors in subjects with type 2 diabetes by pycnogenol supplementation,” Nutr Res, 28. 315-320. 2008.
[10]	Ohishi, N., Ohkawa, H., Miike, A., Tatano, T. and Yagi, K., “A new assay method for lipid peroxides using a methylene blue derivatives,” Biochem Int, 10.205-211. 1985.
[11]	Burton, G.W., Webb, A. and Ingold, K.V., “A mild, rapid, and efficient method of lipid extraction for use in determining vitamin E/lipid ratio,” Lipids, 20.29-39. 1985.
[12]	Lee, J., Park, C.S., Chung, M.Y., Cho, D.H. and Watson, R.R., “Reduced micronutrient intake accentuates premature death caused by immune dysfunction in leukemia retrovirus-infected C57BL/6 mice,” Nutr Res, 25.401-412. 2005.
[13]	Kelly, P., Zulu, I., Amadi, B., Munkanta, M., Banda, J., Rodrigues, L.C., Mabey, D., Feldman, R. and Farthing, M.J.G., “Morbidity and nutritional impariment in relation to CD4 count in a Zambian population with high HIV prevalence,” Acta Tropica, 83. 151-158. 2002.
[14]	Ghone, R.A., Suryakar, A.N., Kulhalli, P.M., Bhagat, S.S., Padalkar, R.K., Karnik, A.C., Hundekar, P.S. and Sangle, D.A., “A Study of Oxidative Stress Biomarkers and Effect of Oral Antioxidant Supplementation in Severe Acute Malnutrition,” J Clin Diagn Res, 7.2146-2148. 2013.
[15]	Wessels, I., Haase, H., Engelhardt, G., Rink, L. and Uciechowski, P., “Zinc deficiency induces production of the proinflammatory cytokines IL-1β and TNFα in promyeloid cells via epigenetic and redox-dependent mechanisms,” J Nutr Biochem, 24.289-297. 2013.
[16]	Parasad, A.S., “Effects of zinc deficiency on Th1 and Th2 cytokine shifts,” J Infect Dis, 182. S62-S68. 2000.
[17]	Dzhagalov, I., Chambon, P. and He, Y.W., “Regulation of CD8+ T lymphocyte effector function and macrophage inflammatory cytokine production by retinoic acid receptor gamma,” J Immunol, 178. 2113-2121. 2007.
[18]	Tamura, T., Fujii, A. and Kuboyama, N., “Antitumor effects of royal jelly (RJ),” Nippon Yakurigaku Zasshi, 89.73-80. 1987.
[19]	Vucevic, D., Melliou, E., Vasilijic, S., Gasic, S., Ivanovski, P., Chinou, I. and Colic, M., “Fatty acids isolated from royal jelly modulate dendritic cell-mediated immune response in vitro,” Int Immunopharm, 7.1211-1220. 2007.
[20]	Liu, F.J., Zhang, Y.X. and Lau, B.H., “Pycnogenol enhances immune and haemopoietic functions in senescence-accelerated mice,” Cell Mol Life Sci, 54.1168-1172. 1998.
[21]	Okamoto, I., Taniguchi, Y., Kunikata, T., Kohno, K., Iwaki, K. and Ikeda, M., “Major royal jelly protein 3 modulates immune responses in vitro and in vivo,” Life Sci, 73(16).2029-2045. 2003.
[22]	Kohno, K., Okamoto, I., Sano, O., Arai, N., Iwaki, K. and Ikeda, M., “Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages,” Biosci Biotechnol Biochem, 68.138-145. 2004.
[23]	Azab, K.S., Bashandy, M., Salem, M., Ahmed, O., Tawfik, Z. and Helal, H., “Royal jelly modulates oxidative stress and tissue injury in gamma irradiated male Wistar albion rats.” N Am J Med Sci, 3. 268-276. 2011.
[24]	Cemek, M., Yilmaz, F., Buyukokuroglu, M.E., Buyukben, A., Aymelek, F. and Ayaz, A., “Serum and liver tissue bio-element levels, and antioxidant enzyme activities in carbon tetracholride-induced hepatotoxicity: protective effects of royal jelly,” J Med Food, 15.747-752. 2012.
[25]	Alvarado, C., Alvarez, P., Puerto, M., Gausserès, N., Jiménez, L. and De, la.Fuente.M., “Dietary supplementation with antioxidants improves functions and decreases oxidative stress of leukocytes from prematurely aging mice,” Nutrition, 22. 767-777. 2006.
[26]	Bubici, C., Papa, S., Dean, K. and Franzoso, G.. “Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance,” Oncogene, 25. 6731-6748. 2006.
[27]	Yang, X.Y., Yang, D.S., Zhang, W., Wang, J.M., Li, C.Y., Hui, Ye., Lei, K.F., Chen, X.F., Shen, N.H., Jin, L.Q. and Wang, J.G., “10-Hydroxy-2-decenoic acid from Royal jelly; a potential medicine for RA,” J Ethnopharmacol, 128.314-321. 2010.
[28]	Sugiyama, T., Takahashi, K., Kuzumaki, A., Tokoro, S., Neri, P. and Mori, H., “Inhibitory mechanism of 10-hydroxy-trans-2-decenoic acid (royal jelly acid) against lipopolysaccharide- and interferon-β-induced nitric oxide production,” Inflammation, 36. 372-378. 2013.
[29]	Vaid, M., Prasad, R., Singh, T., Elmets, C.A., Xu, H. and Katiyar, S.K., “Silymarin inhibits ultraviolet radiation-induced immune suppression through DNA repair-dependent activation of dendritic cells and stimulation of effector T cells,” Biochem Pharmacol, 85. 1066-1076. 2013.